Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M.G. Cavalli, Jaroslav Štěrba, Pim J. French et al.|Cancer Cell|2017Cited by 1.3k
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Vijay Ramaswamy et al.|Journal of Clinical Oncology|2013Cited by 488
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology GroupJoann L. Ater, Ian F. Pollack, Tianni Zhou et al.|Journal of Clinical Oncology|2012Cited by 433
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Thomas Hielscher et al.|The Lancet Oncology|2016Cited by 369
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology GroupKenneth J. Cohen, Ian F. Pollack, Richard L. Heideman et al.|Neuro-Oncology|2011Cited by 342